681 results match your criteria: "Centre for Rheumatic Diseases[Affiliation]"

Objectives: This study aims to explore patients' and clinicians' understanding and experiences of refractory disease (RD) and persistent physical and emotional symptoms (PPES) in patients with inflammatory arthritis (IA), namely rheumatoid arthritis or polyarticular juvenile idiopathic arthritis from their perspectives through interviews and/or focus groups.

Design: A qualitative study was conducted, following a pragmatic epistemology approach with framework analysis employed.

Methods: Semi-structured interviews or focus groups with IA patients (n = 25) and multi-disciplinary rheumatology HCPs (n = 32) were conducted at one time point to obtain participants respective understanding and experiences of managing RD/PPES, and its impact on the patient-professional relationship.

View Article and Find Full Text PDF

Objectives: To establish reference intervals (RIs) for work ability, at-work productivity loss and overall productivity loss in the general working population and to compare work ability and at-work productivity loss of patients with inflammatory rheumatic and musculoskeletal disease (iRMD) with this population.

Methods: Cross-sectional analysis among patients with iRMDs and population controls without iRMDs having paid work and participating in a Dutch cohort study. They reported on three work outcomes: work ability (0-10), at-work productivity loss and overall productivity loss (0%-100%).

View Article and Find Full Text PDF

Introduction: Annual screening for hydroxychloroquine (HCQ) retinopathy is recommended, and electroretinography (ERG) is considered a gold-standard test, but there are screening shortfalls and standard ERG is burdensome and has limited availability. Newer, portable ERG devices using skin-based electrodes may increase screening capacity but need validation. This study aims to determine initial device accuracies and feasibility of further research.

View Article and Find Full Text PDF

Objectives: To update the first-line conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) prescribing pattern, describe change and variation across demographical and geographical factors in the Rheumatoid arthritis (RA) population, and identify individual and hospital factors associated with it.

Methods: This retrospective cohort study included newly diagnosed RA adult patients from 1 May 2018-1 April 2023 in the UK. We used adjusted multinomial logistic regression with random effect to explore associations with different first-line csDMRAD prescription and to account for hospital-level clustering.

View Article and Find Full Text PDF

Objectives: To compare the construct validity, including discrimination between known groups, of three pain and three morning stiffness (MS) measurement instruments.

Methods: Patients with radiographic axial spondyloarthritis with 8-year data from the Outcome in Ankylosing Spondylitis International Study cohort were assessed cross-sectionally. Three instruments for pain and three for MS, all self-reported and scored 0-10, were compared.

View Article and Find Full Text PDF

Patient and public involvement in the design of an international clinical trial: real world experience.

Res Involv Engagem

November 2024

Department of Inflammation and Ageing, College of Medicine and Health, Rheumatology Research Group, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.

Background: The value of patient and public involvement (PPI) during the earliest stages of clinical trial development, and prior to the award of substantive funding, is widely recognised. However, it is often under-resourced and PPI processes during this phase are rarely reported in detail. Having benefitted from seed funding to develop an international clinical trial proposal, we sought to describe and appraise PPI activities and processes that support pre-award co-development.

View Article and Find Full Text PDF
Article Synopsis
  • This study explored the adverse events (AEs) related to COVID-19 vaccination in patients with rheumatoid arthritis (RA) as part of the COVAD-2 study, which surveyed participants from February to June 2022.
  • It included 7203 participants, including 1423 RA patients, and found that RA patients reported higher rates of both major and minor AEs compared to healthy controls, and even more when compared to those with other autoimmune diseases.
  • Active RA significantly increased the risk of major AEs and hospitalization, while patients on certain medications like methotrexate or TNF inhibitors experienced fewer AEs than those not on these treatments.
View Article and Find Full Text PDF

Objective: Performance visualisation tools are increasingly being applied in healthcare to enhance decision-making and improve quality of care. However, there is a lack of comprehensive synthesis of their overall effectiveness and the contextual factors that influence their success in different clinical settings. This study aims to provide a broad synthesis of visualisation interventions not limited to a specific department.

View Article and Find Full Text PDF

Objective: To evaluate temporal and regional variation in biologic and targeted synthetic DMARD (b/tsDMARD) initiation for rheumatoid arthritis (RA) in England and Wales.

Methods: An observational cohort study was conducted for people with RA enrolled in the National Early Inflammatory Arthritis Audit (NEIAA) between May 2018 and April 2022 who had 12-month follow-up data. Temporal trends in escalation to b/tsDMARDs within 12 months of initial rheumatology assessment were explored, including comparisons before and after publication (July 2021) of national guidelines that lowered the threshold for b/tsDMARD initiation to include moderate-severity RA.

View Article and Find Full Text PDF

Introduction: Worldwide, the unmet rehabilitation needs of adults with musculoskeletal disorders are high. Aquatic exercise is clinically effective in managing musculoskeletal disorders, but access to rehabilitative services is limited.

Objective: To determine the feasibility of a community-based aquatic exercise and peer support intervention for patients with musculoskeletal disorders delivered via a multisector partnership between an NHS physiotherapy service, a leisure operator and a social enterprise that creates personalised exercise programmes delivered through an application on a tablet computer.

View Article and Find Full Text PDF
Article Synopsis
  • * The study used data from the National Early Inflammatory Arthritis Audit and included 6098 patients in England and Wales, focusing on those diagnosed between May 2018 and April 2022, analyzing factors influencing the initiation of DMARD treatments within 12 months of their first appointment.
  • * Results showed that only 8.3% of patients started DMARDs in that timeframe, with younger patients (under 40) being significantly more likely to begin treatment compared to older patients over 65, highlighting age-related disparities in accessing care.
View Article and Find Full Text PDF

NK cell subsets define sustained remission in rheumatoid arthritis.

JCI Insight

December 2024

Centre for Inflammation Biology and Cancer Immunology, Floor 1, New Hunt's House, Great Maze Pond, King's College London, Guy's Campus, London, United Kingdom.

Rheumatoid arthritis (RA) is an immune-mediated, chronic inflammatory condition. With modern therapeutics and evidence-based management strategies, achieving sustained remission is increasingly common. To prevent complications associated with prolonged use of immunosuppressants, drug tapering or withdrawal is recommended.

View Article and Find Full Text PDF
Article Synopsis
  • Difficult-to-treat rheumatoid arthritis (D2T RA) affects a significant number of patients, with prevalence rates between 5.5% and 27.5%, arising when treatments fail after using at least two biological or targeted synthetic drugs.
  • The condition is complex, often involving co-morbidities and socioeconomic challenges, but some patients experience persistent symptoms without these issues.
  • A comprehensive approach is essential to understand and address individual patient factors, focusing on both biological and non-biological influences based on emerging data from recent cohort studies.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how comorbidities impact the quality of life in patients with idiopathic inflammatory myopathies (IIMs) compared to other autoimmune diseases and healthy individuals, utilizing self-reported data from the COVAD-2 survey.
  • Results show IIM patients have significantly higher rates of comorbidities, basic multitasking, complex multitasking, and mental health disorders.
  • The presence of these conditions correlates with lower overall physical and mental health scores, suggesting the need for targeted management strategies for IIM patients based on identified clinical clusters.
View Article and Find Full Text PDF

Cardiovascular comorbidities in psoriatic arthritis: state of the art.

Ther Adv Musculoskelet Dis

September 2024

Centre for Rheumatic Diseases, King's College London, Weston Education Centre, Cutcombe Road, London SE5 9RJ, UK.

Article Synopsis
  • * The review discusses the mechanisms behind cardiovascular risks in PsA, including inflammatory cytokines and immune dysregulation, while evaluating current risk assessment tools and suggesting innovative biomarkers for a more accurate risk profile.
  • * Treatment for PsA must consider the balance between effectively managing arthritis symptoms and the potential risks to cardiovascular health, requiring a collaborative approach from various medical specialties to improve overall patient outcomes.
View Article and Find Full Text PDF

Objectives: Physician's evaluation of interstitial lung disease (ILD) extension with high-resolution computed tomography (HRCT) has limitations such as lack of objectivity and reproducibility. This study aimed to investigate the utility of computer-based deep-learning analysis using QZIP-ILD® software (DL-QZIP) compared with conventional approaches in connective tissue disease (CTD) -related ILD.

Methods: Patients with CTD-ILD visiting our Rheumatology Centre between December 2020 and April 2024 were recruited.

View Article and Find Full Text PDF

Establishing partnerships with people with lived experience of mental illness for stigma reduction in low- and middle-income settings.

Glob Ment Health (Camb)

June 2024

Health Service and Population Research Department, Centre for Global Mental Health and Centre for Implementation Science, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.

Social contact refers to the facilitation of connection and interactions between people with and without mental health conditions. It can be achieved, for example, through people sharing their lived experience of mental health conditions, which is an effective strategy for stigma reduction. Meaningful involvement of people with lived experience (PWLE) in leading and co-leading anti-stigma interventions can/may promote autonomy and resilience.

View Article and Find Full Text PDF

Association between interleukin-12 p40 subunit and risk of primary Sjögren's syndrome: a Mendelian randomization study.

Rheumatology (Oxford)

September 2024

Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester, UK.

Objectives: Interleukin-12 (IL-12) signalling was proposed in the immunopathogenesis of primary Sjögren's disease. The efficacy of therapies targeting this pathway is currently unclear. Herein, we investigated the associations between circulating proteins involved in the IL-12 and IL-23 signalling pathways on primary Sjögren's disease using mendelian randomization.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the occurrence of breakthrough COVID-19 infections (BIs) in fully vaccinated patients with systemic lupus erythematosus (SLE) against those with other rheumatic autoimmune diseases (rAIDs), non-rheumatic autoimmune diseases (nrAIDs), and healthy controls (HCs).
  • Results showed that 10.7% of SLE patients reported at least one BI, with frequencies similar to HCs and nrAID patients but higher than those with other rAIDs.
  • Overall, vaccinated SLE patients experienced comparable levels of COVID-19 infection frequency and severity as healthy individuals, with no significant association found between demographic factors or treatments and BIs in SLE patients.
View Article and Find Full Text PDF

Objectives: As a large language model (LLM) trained on a large data set, ChatGPT can perform a wide array of tasks without additional training. We evaluated the performance of ChatGPT on postgraduate UK medical examinations through a systematic literature review of ChatGPT's performance in UK postgraduate medical assessments and its performance on Member of Royal College of Physicians (MRCP) Part 1 examination.

Methods: Medline, Embase and Cochrane databases were searched.

View Article and Find Full Text PDF

Objectives: Anti-synthetase syndrome (ASS) is a chronic autoimmune condition, with interstitial lung disease (ILD) being a key feature. This systematic literature review (SLR; CRD42023416414) aimed to summarize treatments and outcomes of ILD associated with ASS (ASS-ILD).

Methods: Databases were searched for articles discussing ASS-ILD management and outcomes, published 1946-September 2023.

View Article and Find Full Text PDF